Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Serracant-Prat A"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
null Riekje Winzer, null Arnau Serracant Prat, null Valerie J. Brock, null Carolina Pinto‐Espinoza, null Björn Rissiek, null Miriam Amadi, null Niklas Eich, null Anne Rissiek, null Enja Schneider, null Tim Magnus, null Andreas H. Guse, null Björn‐Philipp Diercks, null Friedrich Koch‐Nolte, null Eva Tolosa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::651b8370900f27bb0a80d74c6ed9bc74
https://doi.org/10.1002/eji.202249932/v3/response1
https://doi.org/10.1002/eji.202249932/v3/response1
Autor:
Riekje Winzer, Arnau Serracant‐Prat, Valerie J. Brock, Carolina Pinto‐Espinoza, Björn Rissiek, Miriam Amadi, Niklas Eich, Anne Rissiek, Enja Schneider, Tim Magnus, Andreas H. Guse, Björn‐Philipp Diercks, Friedrich Koch‐Nolte, Eva Tolosa
Publikováno v:
European journal of immunologyReferences. 52(11)
Extracellular ATP activates the P2X7 receptor, leading to inflammasome activation and release of pro-inflammatory cytokines in monocytes. However, a detailed analysis of P2X7 receptor expression and function in the human T cell compartment has not be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac26bac741665bba65387613eb21676f
https://pubmed.ncbi.nlm.nih.gov/36178227
https://pubmed.ncbi.nlm.nih.gov/36178227
Autor:
Irma Pujol-Autonell, Arnau Serracant-Prat, Mary Cano-Sarabia, Rosa M Ampudia, Silvia Rodriguez-Fernandez, Alex Sanchez, Cristina Izquierdo, Thomas Stratmann, Manuel Puig-Domingo, Daniel Maspoch, Joan Verdaguer, Marta Vives-Pi
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0127057 (2015)
INTRODUCTION:The development of new therapies to induce self-tolerance has been an important medical health challenge in type 1 diabetes. An ideal immunotherapy should inhibit the autoimmune attack, avoid systemic side effects and allow β-cell regen
Externí odkaz:
https://doaj.org/article/056eec6766aa4825bbef202daf7373c2
Autor:
Pujol-Autonell, Irma1, Serracant-Prat, Arnau1, Cano-Sarabia, Mary2, Ampudia, Rosa M.1, Rodriguez-Fernandez, Silvia1, Sanchez, Alex3, Izquierdo, Cristina4, Stratmann, Thomas4, Puig-Domingo, Manuel5, Maspoch, Daniel2,6, Verdaguer, Joan7, Vives-Pi, Marta1 mvives@igtp.cat
Publikováno v:
PLoS ONE. Jun2015, Vol. 10 Issue 6, p1-19. 19p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Friedrich Koch-Nolte, Eva Tolosa, Friedrich Haag, Wendy Rotthier, Eric Boué-Grabot, Philine Bergmann, Björn Rissiek, Welbeck Danquah, Joana Assuncao, Nicole Schwarz, Jan-Hendrik Knop, Catherine Meyer-Schwesinger, Tim Magnus, Anna Hammel, Domenica Iacenda, Arnau Serracant-Prat, Carolina Pinto, Peter Bannas, Catelijne Stortelers, Toon Laeremans, Miriam Amadi
Publikováno v:
Science Translational Medicine
Science Translational Medicine, American Association for the Advancement of Science, 2016, 8 (366), pp.366ra162-366ra162. ⟨10.1126/scitranslmed.aaf8463⟩
Science Translational Medicine, American Association for the Advancement of Science, 2016, 8 (366), pp.366ra162. ⟨10.1126/scitranslmed.aaf8463⟩
Science Translational Medicine, American Association for the Advancement of Science, 2016, 8 (366), pp.366ra162-366ra162. ⟨10.1126/scitranslmed.aaf8463⟩
Science Translational Medicine, American Association for the Advancement of Science, 2016, 8 (366), pp.366ra162. ⟨10.1126/scitranslmed.aaf8463⟩
International audience; Ion channels are desirable therapeutic targets, yet ion channel-directed drugs with high selectivity and few side effects are still needed. Unlike small-molecule inhibitors, antibodies are highly selective for target antigens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17b68a5148cba77b32364230b1c93863
https://pubmed.ncbi.nlm.nih.gov/27881823
https://pubmed.ncbi.nlm.nih.gov/27881823
Autor:
Pujol-Autonell, Irma, Serracant Prat, Arnau, Cano-Sarabia, Mary, Ampudia Carrasco, Rosa María, Rodriguez Fernandez, Silvia, Sánchez, Alex, Izquierdo Castro, Cristina, Stratmann, Thomas, Puig Domingo, Manuel, Maspoch Comamala, Daniel, Verdaguer, Joan, Vives Pi, Marta, Universitat Autònoma de Barcelona
Publikováno v:
PLoS ONE
Recercat. Dipósit de la Recerca de Catalunya
instname
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio Abierto de la UdL
Universitad de Lleida
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Digital.CSIC. Repositorio Institucional del CSIC
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE, Vol 10, Iss 6, p e0127057 (2015)
Recercat. Dipósit de la Recerca de Catalunya
instname
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio Abierto de la UdL
Universitad de Lleida
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Digital.CSIC. Repositorio Institucional del CSIC
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE, Vol 10, Iss 6, p e0127057 (2015)
This is an open access article distributed under the terms of the Creative Commons Attribution License.-- et al.
[Introduction]: The development of new therapies to induce self-tolerance has been an important medical health challenge in type 1 d
[Introduction]: The development of new therapies to induce self-tolerance has been an important medical health challenge in type 1 d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc9b83dd772032ac0ea58a328585bd0b
https://pubmed.ncbi.nlm.nih.gov/26039878
https://pubmed.ncbi.nlm.nih.gov/26039878
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.